This Week in Psychedelics

Research suggests microdosing reduces anxiety and depression, and the first formal test of the effect of psychedlics on metaphysical beliefs.

November 26, 2021

This Week...

More headway was made this week regarding how we understand the effectiveness (or lack of effectiveness) of microdosing. According to an analysis published by Scientific Reports, subjects of a recent microdosing study reported health related motivations and lower levels of anxiety and depression compared to non-microdosers. You can read more about that study here:

Former Texas Governor Rick Perry was recently spotted promoting psychedelics research for veterans at an event hosted by the group, Veterans Exploring Treatment Solutions, where he was joined by M.A.P.S. founder Rick Doblin and author and philanthropist Tim Ferris. Perry first announced his support for psychedelics research back in April, but has since become an outspoken advocate of psychedelics research. Here’s more:

Can the use of psychedelics induce lasting changes in metaphysical beliefs? While most folks who have taken psychedelics would likely argue that they can, there’s still never been any formal testing on this subject. Until now. Check it out:

Did You Know?

Did you know there’s a connection between LSD and COVID-19 testing? 

The technique used to analyze whether or not someone has the pathogen that causes COVID-19 is called polymerase chain reaction (PCR). When accurate, PCR can help confirm positive cases.  

The man who invented PCR, biochemist Kary Mullis, revealed to Albert Hoffman that his use of LSD was a major contributing factor for the development of PCR.